These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11494170)

  • 1. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
    Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
    J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.
    Qadri F; Ryan ET; Faruque AS; Ahmed F; Khan AI; Islam MM; Akramuzzaman SM; Sack DA; Calderwood SB
    Infect Immun; 2003 Aug; 71(8):4808-14. PubMed ID: 12874365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
    Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
    Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weak serum and intestinal antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients.
    Svennerholm AM; Levine MM; Holmgren J
    Infect Immun; 1984 Sep; 45(3):792-4. PubMed ID: 6469362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh.
    Harris JB; Podolsky MJ; Bhuiyan TR; Chowdhury F; Khan AI; Larocque RC; Logvinenko T; Kendall J; Faruque AS; Nagler CR; Ryan ET; Qadri F; Calderwood SB
    PLoS Negl Trop Dis; 2009; 3(3):e403. PubMed ID: 19333369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of gut immunologic reactions: selective induction of distinct responses to Vibrio cholerae WO7 and its toxin.
    Walia K; Vohra H; Singh H; Ganguly NK
    Microbiol Immunol; 2000; 44(11):931-40. PubMed ID: 11145274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
    Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
    Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of chitosan nanoparticles containing CtxB antigen against Vibrio cholera.
    Tabrizi NM; Amani J; Ebrahimzadeh M; Nazarian S; Kazemi R; Almasian P
    Microb Pathog; 2018 Nov; 124():170-177. PubMed ID: 30138759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.
    Kauffman RC; Bhuiyan TR; Nakajima R; Mayo-Smith LM; Rashu R; Hoq MR; Chowdhury F; Khan AI; Rahman A; Bhaumik SK; Harris L; O'Neal JT; Trost JF; Alam NH; Jasinskas A; Dotsey E; Kelly M; Charles RC; Xu P; Kováč P; Calderwood SB; Ryan ET; Felgner PL; Qadri F; Wrammert J; Harris JB
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies enhance interaction of Vibrio cholerae with intestinal M-like cells.
    Blanco LP; Dirita VJ
    Infect Immun; 2006 Dec; 74(12):6957-64. PubMed ID: 17000721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.
    Asaduzzaman M; Ryan ET; John M; Hang L; Khan AI; Faruque AS; Taylor RK; Calderwood SB; Qadri F
    Infect Immun; 2004 Aug; 72(8):4448-54. PubMed ID: 15271902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholera immunology and the molecular biology of cholera toxin. Recent progress and future prospects].
    Carrada Bravo T
    Rev Alerg; 1993; 40(4):91-4. PubMed ID: 8143024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.